Today: 19 May 2026
NatWest share price slips in early London trade after fresh buyback update
24 February 2026
1 min read

NatWest share price slips in early London trade after fresh buyback update

London, Feb 24, 2026, 08:26 GMT — Regular session

  • NatWest fell 1.3% out of the gate, slipping to 602.4p from an opening print of 611.4p.
  • The bank revealed it executed another round of buybacks on Feb. 23, part of its existing programme.
  • Tariff-related volatility is on investors’ radar, along with upcoming shareholder and dividend milestones at NatWest.

NatWest Group slipped 1.3% to 602.4 pence during early Tuesday trading in London. Shares started the session at 611.4 pence before touching a low of 600.0.

Late Monday, the bank reported it repurchased 782,352 shares on Feb. 23, paying volume-weighted averages of 613.65 pence on the LSE, 614.83 pence on CHIX, and 614.93 pence on BATE.

Timing is key here: when volatility jumps, investors tend to dump bank stocks first. U.S. financials took a hit Monday—markets struggled with fresh tariff jitters, and concerns flared up again about growth and the cost to borrow.

NatWest said UBS carried out the buybacks, acting on instructions from Feb. 16. The bank plans to cancel those shares, trimming its share count over time. Once the settlement goes through, NatWest expects to keep 217,946,642 shares in treasury—shares it owns itself—while leaving 7,978,074,610 shares in issue, not counting the treasury stock.

Still, buybacks aren’t a guaranteed safety net for shares. Should the market shift back into defensive mode, banks may come under pressure—concerns over loan losses, sluggish deal activity, and abrupt changes in rate expectations can all drag on the sector.

After hiking its profit for the year and bumping up its longer-range goals earlier this month, NatWest has been doubling down on its image as a UK-focused lender, now touting a larger wealth business.

The company has struck a deal to acquire Evelyn Partners, a wealth manager, for £2.7 billion—a move aimed at expanding its fee-based revenue streams.

Traders are eyeing the lows to see if the stock holds steady there after the open. Another thing on the radar: daily disclosures—will buyback tape keep turning up?

NatWest shareholders are set for the AGM on April 28. As for the final dividend, it’s marked ex-dividend on March 19 and slated to be paid out May 5, the exchange diary shows.

Stock Market Today

  • Western Digital Leverages Post-Quantum Cryptography to Enhance AI Data Security
    May 19, 2026, 9:57 AM EDT. Western Digital Corporation (WDC) integrates post-quantum cryptography (PQC) into its Ultrastar UltraSMR hard drives to address future AI data security risks. The drives, undergoing qualification with hyperscale customers, embed PQC directly into storage firmware, enhancing protection against quantum-era threats by ensuring firmware integrity and secure key management. Using NIST-aligned ML-DSA-87 and RSA-3072 algorithms, WDC advances device-level trust with dual-signing strategies. This positions WDC ahead in quantum-resistant enterprise storage security. Competitor Seagate Technology (STX) continues focusing on durable, cost-efficient storage solutions amid rising AI data demands, while WDC's split into SanDisk aims to capitalize further on AI-driven markets.

Latest articles

Bakkt Up Early After Director Buys $4.85M in Shares

Bakkt Up Early After Director Buys $4.85M in Shares

19 May 2026
Bakkt shares jumped 14.2% to $9.96 in pre-market trading Tuesday after a filing showed director Michael Alfred’s vehicle bought $4.85 million in stock. SEC documents said Alfred acquired 585,000 shares last week via Alpine Fox LP. CEO Akshay Naheta exercised options for 33,557 shares at $10 each. Bakkt recently reported Q1 revenue of $243.6 million, down sharply from a year earlier.
Relay Therapeutics Shares Rise In Pre-Market Ahead Of Key Drug Update

Relay Therapeutics Shares Rise In Pre-Market Ahead Of Key Drug Update

19 May 2026
Relay Therapeutics shares jumped 11.3% to $13.47 in premarket trading Tuesday after reporting a 60% volumetric response rate in 20 evaluable patients from its Phase 2 trial of zovegalisib for vascular anomalies. The company said 95% of patients saw some lesion reduction at 12 weeks. No patients discontinued due to adverse events. The regular Nasdaq session was set to open at 9:30 a.m. ET.

Popular

Destiny Tech100 Gains Pre-Market as SpaceX IPO Buzz Mixes With AI Stock Warnings

Destiny Tech100 Gains Pre-Market as SpaceX IPO Buzz Mixes With AI Stock Warnings

18 May 2026
Destiny Tech100 Inc. shares rose 10.6% to $52.68 in early premarket trading Monday after reports that SpaceX may list on Nasdaq as soon as June 12 at a $1.75 trillion valuation. DXYZ’s portfolio includes about 14.4% exposure to SpaceX and 18.1% to Anthropic. The stock ended last week down 13% despite sharp swings. Destiny’s shares last closed at nearly double their reported net asset value.
Shell share price today: What to watch before London opens as oil jumps and buybacks roll on
Previous Story

Shell share price today: What to watch before London opens as oil jumps and buybacks roll on

National Grid share price ticks up as Ofgem flags AI data-centre power crunch
Next Story

National Grid share price ticks up as Ofgem flags AI data-centre power crunch

Go toTop